Diego Signorelli

4.5k total citations
84 papers, 1.6k citations indexed

About

Diego Signorelli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Diego Signorelli has authored 84 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 54 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Diego Signorelli's work include Cancer Immunotherapy and Biomarkers (41 papers), Lung Cancer Treatments and Mutations (30 papers) and Lung Cancer Research Studies (20 papers). Diego Signorelli is often cited by papers focused on Cancer Immunotherapy and Biomarkers (41 papers), Lung Cancer Treatments and Mutations (30 papers) and Lung Cancer Research Studies (20 papers). Diego Signorelli collaborates with scholars based in Italy, United States and Switzerland. Diego Signorelli's co-authors include Marina Chiara Garassino, Claudia Proto, Giuseppe Lo Russo, Monica Ganzinelli, Filippo de Braud, Martina Imbimbo, Giulia Galli, Roberto Ferrara, Nicoletta Zilembo and Alessandro De Toma and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Diego Signorelli

82 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Diego Signorelli Italy	21	1.2k	686	344	216	196	84	1.6k
Susan M. Hiniker United States	20	702 0.6×	627 0.9×	383 1.1×	266 1.2×	181 0.9×	108	1.6k
Kristen A. Marrone United States	16	1.5k 1.3×	761 1.1×	458 1.3×	418 1.9×	190 1.0×	74	2.0k
Leila Khoja United Kingdom	20	1.7k 1.4×	612 0.9×	416 1.2×	403 1.9×	388 2.0×	50	2.1k
Giovanni Fucà Italy	23	1.2k 1.0×	549 0.8×	382 1.1×	293 1.4×	204 1.0×	87	1.8k
Ryan D. Gentzler United States	20	2.1k 1.8×	1.4k 2.0×	285 0.8×	426 2.0×	219 1.1×	86	2.5k
Chan-Young Ock South Korea	21	1.0k 0.9×	508 0.7×	309 0.9×	286 1.3×	255 1.3×	42	1.4k
Sujana Movva United States	17	590 0.5×	618 0.9×	182 0.5×	131 0.6×	104 0.5×	67	1.1k
Motohiro Tamiya Japan	23	1.2k 1.0×	1.3k 1.9×	317 0.9×	96 0.4×	189 1.0×	163	1.9k
Akihiro Tamiya Japan	23	1.3k 1.1×	1.2k 1.8×	283 0.8×	76 0.4×	253 1.3×	110	1.8k
Ji‐Young Choe South Korea	19	699 0.6×	585 0.9×	290 0.8×	99 0.5×	238 1.2×	54	1.2k

Countries citing papers authored by Diego Signorelli

Since Specialization

Citations

This map shows the geographic impact of Diego Signorelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Signorelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Signorelli more than expected).

Fields of papers citing papers by Diego Signorelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Signorelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Signorelli. The network helps show where Diego Signorelli may publish in the future.

Co-authorship network of co-authors of Diego Signorelli

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Signorelli. A scholar is included among the top collaborators of Diego Signorelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Signorelli. Diego Signorelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Proto, Claudia, Giuseppe Lo Russo, Arsela Prelaj, et al.. (2025). Tracking the Response to Immunotherapy: Blood microRNA Dynamics in Patients With Advanced Non–Small Cell Lung Cancer. JCO Precision Oncology. 9(9). e2400790–e2400790. 1 indexed citations

Proto, Claudia, Arsela Prelaj, Laura Mazzeo, et al.. (2025). 40P: Metformin plus/minus cyclic fasting mimicking diet to improve the efficacy of first-line chemo-immunotherapy in advanced LKB1-inactive NSCLC: Results of the phase II trial FAME. Journal of Thoracic Oncology. 20(3). S36–S37. 1 indexed citations

Marando, Alessandro, Emanuele Valtorta, Calogero Lauricella, et al.. (2024). Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature. Pathologica. 116(1). 13–21. 1 indexed citations

Bogani, Giorgio, Michela Cinquini, Diego Signorelli, et al.. (2023). A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS study. Critical Reviews in Oncology/Hematology. 187. 104016–104016. 15 indexed citations

Pizzutilo, Elio Gregory, Valentina Motta, Calogero Lauricella, et al.. (2023). Repotrectinib Overcomes F2004V Resistance Mutation in ROS1-Rearranged NSCLC: A Case Report. JTO Clinical and Research Reports. 4(11). 100555–100555. 5 indexed citations

Toma, Alessandro De, Giuseppe Lo Russo, Diego Signorelli, et al.. (2021). Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake. Critical Reviews in Oncology/Hematology. 160. 103299–103299. 5 indexed citations

Ferrara, Roberto, Diego Signorelli, Claudia Proto, et al.. (2021). Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations. Translational Lung Cancer Research. 10(6). 2955–2969. 6 indexed citations

Petrelli, Fausto, Alessandro Iaculli, Diego Signorelli, et al.. (2020). Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis. Preprints.org. 11 indexed citations

Ferrara, Roberto, Francesco Facchinetti, Giuseppina Calareso, et al.. (2020). 1278P Hyperprogressive disease (HPD) upon first-line PD-1/PD-L1 inhibitors (ICI) as single agent or in combination with platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients (pts). Annals of Oncology. 31. S826–S826. 7 indexed citations

10.

Prelaj, Arsela, Claudia Proto, Giuseppe Lo Russo, et al.. (2020). 1388P Poziotinib in advanced NSCLC with EGFR or HER2 exon 20 insertion mutation: Initial results from a single site expanded access program. Annals of Oncology. 31. S882–S882. 5 indexed citations

11.

Lobefaro, Riccardo, Giuseppe Viscardi, Raimondo Di Liello, et al.. (2020). 1329P Immune checkpoint inhibitors in advanced NSCLC patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers in a real world experience. Annals of Oncology. 31. S856–S857. 1 indexed citations

12.

Boeri, Mattia, Massimo Milione, Claudia Proto, et al.. (2019). Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study. Clinical Cancer Research. 25(7). 2166–2173. 64 indexed citations

13.

Galli, Giulia, Tiziana Triulzi, Claudia Proto, et al.. (2019). Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer. Lung Cancer. 132. 72–78. 53 indexed citations

14.

Randon, Giovanni, Giulia Galli, Alessandro De Toma, et al.. (2019). P1.01-135 Salvage Chemotherapy After Immunotherapy Failure in Non-Small-Cell Lung Cancer Patients. Journal of Thoracic Oncology. 14(10). S416–S416. 1 indexed citations

15.

Boeri, Mattia, Massimo Milione, Diego Signorelli, et al.. (2018). MA04.07 MicroRNA-Based Liquid Biopsy Combines with PD-L1 Tumor Expression to Predict Response to Immunotherapy in Advance NSCLC Patients. Journal of Thoracic Oncology. 13(10). S368–S369. 2 indexed citations

16.

Galli, Giulia, M. Poggi, Giovanni Fucà, et al.. (2018). MA10.02 Impact of Antibiotics on Outcome of Metastatic Non Small Cell Lung Cancer Patients Treated with Immunotherapy. Journal of Thoracic Oncology. 13(10). S389–S389. 3 indexed citations

17.

Signorelli, Diego, Claudia Proto, Monica Ganzinelli, et al.. (2016). 209P: SMO mutation is a strong negative prognostic factor in malignant pleural mesothelioma. Journal of Thoracic Oncology. 11(4). S147–S147. 1 indexed citations

18.

Pusceddu, Sara, Giuseppe Lo Russo, Marianna Macerelli, et al.. (2016). Diagnosis and management of typical and atypical lung carcinoids. Critical Reviews in Oncology/Hematology. 100. 167–176. 23 indexed citations

19.

Grande, Roberta, Clara Natoli, Ida Pavese, et al.. (2016). Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis. PLoS ONE. 11(7). e0157751–e0157751. 14 indexed citations

20.

Rossi, Bárbara, Giovanni Schinzari, Giulio Maccauro, et al.. (2010). Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis. BMC Musculoskeletal Disorders. 11(1). 34–34. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact